Abstract
The aim of this paper was to present the etiological factors responsible for temporomandibular joint dysfunction associated with psychoemotional disorders and possible drug therapy. Etiology of this disorder is multifactorial. The term “stress” was explained, together with its influence on the human body and its long-term effects. We emphasized the significance of factors that affect individual reaction to stress and patients’ personality features favoring incorrect behavioral pattern. We also presented the mechanism of adverse effect of stress on temporomandibular muscles and joints via the limbic system and gamma loop as well as the role of temporomandibular reflexive regulation mechanisms. We explained the differences in reactivity between skeletal and masticatory muscles to stress-inducing factors resulting from different embryonic origin, morphology, and biochemical reactions during muscle contraction and presented drug therapy.
Keywords: Temporomandibular joint dysfunction, depression, limbic system, stress, pharmacological treatment, occlusal splint.
Letters in Drug Design & Discovery
Title:Psychoemotional Background of Temporomandibular Joint Dysfunction and Possible Drug Therapy
Volume: 12 Issue: 9
Author(s): Pihut Malgorzata, Gierowski Krzysztof, Ceranowicz Piotr and Ferendiuk Ewa
Affiliation:
Keywords: Temporomandibular joint dysfunction, depression, limbic system, stress, pharmacological treatment, occlusal splint.
Abstract: The aim of this paper was to present the etiological factors responsible for temporomandibular joint dysfunction associated with psychoemotional disorders and possible drug therapy. Etiology of this disorder is multifactorial. The term “stress” was explained, together with its influence on the human body and its long-term effects. We emphasized the significance of factors that affect individual reaction to stress and patients’ personality features favoring incorrect behavioral pattern. We also presented the mechanism of adverse effect of stress on temporomandibular muscles and joints via the limbic system and gamma loop as well as the role of temporomandibular reflexive regulation mechanisms. We explained the differences in reactivity between skeletal and masticatory muscles to stress-inducing factors resulting from different embryonic origin, morphology, and biochemical reactions during muscle contraction and presented drug therapy.
Export Options
About this article
Cite this article as:
Malgorzata Pihut, Krzysztof Gierowski, Piotr Ceranowicz and Ewa Ferendiuk, Psychoemotional Background of Temporomandibular Joint Dysfunction and Possible Drug Therapy, Letters in Drug Design & Discovery 2015; 12 (9) . https://dx.doi.org/10.2174/1570180812666150430002404
DOI https://dx.doi.org/10.2174/1570180812666150430002404 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Repetitive Transient Phosphodiesterase-3 Inhibition Eliminates Non-ischemic Cardiac Remodeling and Failure
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial (Thematic Issue: From Nuisance to State-of-the-Art: FDG-PET/CT Imaging of Infection and Inflammation)
Current Molecular Imaging (Discontinued) Insulin Therapy for Improving Cardiac Surgical Outcomes
Current Drug Targets Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A<sub>2</sub> (Lp-PLA<sub>2</sub>) Bound to LDL and HDL
Current Pharmaceutical Design Mitochondrial Triglyceride Transfer Protein Inhibition: New Achievements in the Treatment of Dyslipidemias
Current Pharmaceutical Design Thromboxane Synthase Inhibitors and Thromboxane A2 Receptor Antagonists: A Quantitative Structure Activity Relationships (QSARs) Analysis
Current Medicinal Chemistry Editorial (Thematic Issue: Protection, Repair and Regeneration of Achybreaky Heart)
Current Drug Targets Therapeutic Targets for Heart Failure: Beyond Beta-Adrenergic and Renin-Angiotensin System Blockade
Recent Patents on Cardiovascular Drug Discovery Discussion on Pharmacogenetic Interaction in G6PD Deficiency and Methods to Identify Potential Hemolytic Drugs
Cardiovascular & Hematological Disorders-Drug Targets The Impact of Docosahexaenoic Acid on Alzheimer’s Disease: Is There a Role of the Blood-Brain Barrier?
Current Clinical Pharmacology Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Neuroprotective Role of Repetitive Transcranial Magnetic Stimulation (rTMS) for Neurodegenerative Diseases: A Short Review on Experimental Studies
Mini-Reviews in Medicinal Chemistry Genetic Determinants of HDL Metabolism
Current Medicinal Chemistry The Follow-Up of Dietary Treatment of Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Management of Obesity in Patients with Type 2 Diabetes Mellitus
Current Diabetes Reviews Functional Non-Synonymous Polymorphisms Prediction Methods: Current Approaches and Future Developments
Current Medicinal Chemistry Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Biomarker for Non – Acute Kidney Injury (AKI) Diseases
Inflammation & Allergy - Drug Targets (Discontinued) IL-1 Cytokines in Cardiovascular Disease: Diagnostic, Prognostic and Therapeutic Implications
Cardiovascular & Hematological Agents in Medicinal Chemistry L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?
Letters in Drug Design & Discovery Nutraceuticals - An Emerging Era in the Treatment and Prevention of Cardiovascular Diseases
Current Pharmaceutical Biotechnology